2 min read
Diversifying Clinical Trials: Navigating the FDA's Roadmap for Inclusive Research
In April 2022, the FDA released draft guidance with recommendations for drug developers and clinical trial researchers. The guidance highlights gaps...
2 min read
In April 2022, the FDA released draft guidance with recommendations for drug developers and clinical trial researchers. The guidance highlights gaps...
2 min read
Rare Disease Day will take place on February 29th this year and is a global opportunity to raise awareness for the individuals and families facing...
4 min read
In the ever-evolving landscape of healthcare, a challenge persists – the unequal distribution, access, and quality of care for individuals. In...
2 min read
Therapeutic innovation drives patient treatment updates and improves patient outcomes. From the development of chemotherapy to monoclonal antibody...
3 min read
Payors are major stakeholders in the US healthcare system and shape patient access, health spending, and reimbursement. In this blog post, we will...
4 min read
Beyond reviewing and approving drugs, the FDA plays a pivotal role in overseeing and approving medical devices, a realm defined by its innovation,...
2 min read
In today's fast-paced world, where information overload is the norm, the need for evidence-based decision-making has never been greater. Systematic...
3 min read
The recent approval of Narcan as an over-the-counter drug is a landmark decision that has the potential to save thousands of lives and highlights the...
6 min read
The journey from the research lab to a patient’s bedside for a drug is long, costly, and risky. Manufacturers make significant investments over many...
2 min read
Empowered patients, better outcomes —